These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The biochemistry of the complications of diabetes mellitus. Brownlee M; Cerami A Annu Rev Biochem; 1981; 50():385-432. PubMed ID: 6168237 [No Abstract] [Full Text] [Related]
5. The sorbitol pathway and the complications of diabetes. Gabbay KH N Engl J Med; 1973 Apr; 288(16):831-6. PubMed ID: 4266466 [No Abstract] [Full Text] [Related]
6. Metabolic abnormalities contributing to diabetic complications. I. Glucose metabolism in insulin-insensitive pathways. Anderson JW Am J Clin Nutr; 1975 Mar; 28(3):273-80. PubMed ID: 123410 [No Abstract] [Full Text] [Related]
7. Insulin, glucose and lipid levels in mild diabetics in relation to complications. Fraser R; Lowy C; Elkeles RS; Lewis B; Mancini M Adv Metab Disord; 1973; 2():Suppl 2:83-101. PubMed ID: 4720391 [No Abstract] [Full Text] [Related]
8. [Pathobiochemistry of the late-onset diabetic syndrome]. Wieland OH Med Klin; 1974 Sep; 69(36):1417-23. PubMed ID: 4437430 [No Abstract] [Full Text] [Related]
9. [Sorbitol route of glucose metabolism and complication of diabetes mellitus]. Efimov AS; Skrobonskaia NA; Petakh NN Probl Endokrinol (Mosk); 1980; 26(3):86-90. PubMed ID: 6773043 [No Abstract] [Full Text] [Related]
10. The role of growth hormone in the pathogenesis of vascular complications of diabetes mellitus. Rehman HU Am J Med Sci; 2000 Aug; 320(2):128-34. PubMed ID: 10981489 [No Abstract] [Full Text] [Related]
12. [Physiopathology of chronic complications in diabetes: therapeutic implications]. Balasse EO Brux Med; 1979 Oct; 59(10):435-40. PubMed ID: 546475 [No Abstract] [Full Text] [Related]
13. Insulin antibody binding in diabetes mellitus and factitious hypoglycemia. Palumbo PJ; Molnar GD; Taylor WF; Moxness KE; Tauxe WN Mayo Clin Proc; 1969 Oct; 44(10):725-37. PubMed ID: 5344806 [No Abstract] [Full Text] [Related]
14. [Diabetic cataract and modern views on the etiology and pathogenesis of vascular complications during diabetes]. Dawidowicz A Wiad Lek; 1971 Mar; 24(6):545-8. PubMed ID: 4929053 [No Abstract] [Full Text] [Related]
15. Glycosylation of proteins: its implications in diabetic control and complications. Kirschenbaum DM Pediatr Clin North Am; 1984 Jun; 31(3):611-21. PubMed ID: 6374590 [TBL] [Abstract][Full Text] [Related]
16. [The biochemical basis of the complications of diabetes]. Gabbay KH Journ Annu Diabetol Hotel Dieu; 1984; ():307-20. PubMed ID: 6443221 [No Abstract] [Full Text] [Related]
17. [Sorbitol, phosphoinositides and Na K-ATPase in the pathogenesis of diabetic complications]. Greene DA; Sima AA; Lattimer SA Journ Annu Diabetol Hotel Dieu; 1988; ():105-17. PubMed ID: 2845181 [No Abstract] [Full Text] [Related]
18. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330 [TBL] [Abstract][Full Text] [Related]
19. [Role of the polyol pathway in the occurrence of degenerative complications of diabetes]. Bosquet F; Grimaldi A Presse Med; 1986 May; 15(19):879-83. PubMed ID: 3012508 [TBL] [Abstract][Full Text] [Related]
20. Serial changes in glucose utilization and insulin and growth hormone secretion in acute cerebrovascular disease. Huff TA; Lebovitz HE; Heyman A; Davis L Stroke; 1972; 3(5):543-52. PubMed ID: 4652729 [No Abstract] [Full Text] [Related] [Next] [New Search]